Cantor Fitzgerald Reiterates “Overweight” Rating for Agios Pharmaceuticals (NASDAQ:AGIO)
Agios Pharmaceuticals (NASDAQ:AGIO – Get Free Report)‘s stock had its “overweight” rating reissued by stock analysts at Cantor Fitzgerald in a research report issued on Friday, Benzinga reports. Several other equities analysts have also issued reports on AGIO. The Goldman Sachs Group boosted their price target on Agios Pharmaceuticals from $33.00 to $53.00 and gave […]
22 Sep 07:37 · The Markets Daily